InvestorsHub Logo

ou71764

02/03/19 12:13 AM

#212173 RE: notbrad #212163

notbrad, thank you for attending the meeting and posting all your comments. Very much appreciated.

I definitely think that LP wants the trial to succeed - why wouldn't she? She is not an enemy of shareholders, even with her big salary.

But I am not as optimistic as others. I think NWBO is winging it. Occasionally that works and it might in this case as well. I don't know

But this isn't SOP for a drug trial, the way NWBO is conducting the trial and releasing information. No other trial from another company has this constant dropping of crumbs that require shareholders to digest a few, and then try to figure out what's going on.

It doesn't take a year or two - or whatever it will be - to end the trial and get the data. They don't have to spend months traveling to 80 sites to see if everything was done OK.

If this trial doesn't end shortly - and IMO it won't - then the land sale, good as it was, won't be enough to get us across the goal line. I am expecting another dilution before topline results.

I don't want to be so negative and irritable. I recently found out that a friend of mine has GBM. He is positive and healthier than a lot of patients, but he knows the prognosis.

So 15 years after NWBO started therapy, it seems like a weak promise that with just a little more time, NWBO will have a platform to transform cancer therapy. Sure they will...just another few months...